HomeXBRANE • STO
add
Xbrane Biopharma AB
Previous close
kr 7.44
Day range
kr 7.20 - kr 7.88
Year range
kr 5.42 - kr 38.10
Market cap
158.66M SEK
Avg Volume
42.48K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 9.09M | -86.19% |
Operating expense | 23.26M | — |
Net income | -26.48M | — |
Net profit margin | -291.41 | — |
Earnings per share | -0.06 | 98.50% |
EBITDA | -16.01M | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.59M | -30.36% |
Total assets | 671.62M | -20.28% |
Total liabilities | 110.97M | -82.49% |
Total equity | 560.65M | — |
Shares outstanding | 20.61M | — |
Price to book | 0.27 | — |
Return on assets | -7.86% | — |
Return on capital | -8.95% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -26.48M | — |
Cash from operations | -67.56M | — |
Cash from investing | 4.76M | — |
Cash from financing | 57.43M | — |
Net change in cash | -6.97M | — |
Free cash flow | -57.88M | — |
About
CEO
Founded
2008
Website
Employees
29
